Sp1100
ENDOSCOPIC SLEEVE GASTRECTOMY: READY FOR PRIMETIME?
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
Get an update on the leading controversies in therapeutic endoscopy in 2023 including disposable endoscopes, endoscopic resection, competency in EMR, cholangioscopy, and endoscopic sleeve gastrectomy. LIVE STREAM SESSION
Get an update on the leading controversies in therapeutic endoscopy in 2023 including disposable endoscopes, endoscopic resection, competency in EMR, cholangioscopy, and endoscopic sleeve gastrectomy. LIVE STREAM SESSION
Presenter
Weill Cornell Medical Center
Tracks
Related Products
PANEL DISCUSSION
Get an update on the leading controversies in therapeutic endoscopy in 2023 including disposable endoscopes, endoscopic resection, competency in EMR, cholangioscopy, and endoscopic sleeve gastrectomy…
A RANDOMIZED, DOUBLE-BLIND, TWO-WAY CROSSOVER STUDY TO EVALUATE THE EFFICACY OF LIRAGLUTIDE TREATMENT IN PATIENTS UNDERGOING TRANSORAL OUTLET REDUCTION ENDOSCOPY
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
